Bellerophon Therapeutics, Inc. Common Stock (BLPH ... Find the latest Earnings Report Date for Bellerophon Therapeutics, Inc. Common Stock (BLPH) BLPH Bellerophon Therapeutics, Inc. Common Stock. Zacks Investment Research. NASDAQ:BLPH Bellerophon Therapeutics Earnings Date ... Bellerophon Therapeutics (NASDAQ:BLPH) Earnings Information. Bellerophon Therapeutics last posted its quarterly earnings results on May 11th, 2020. The biotechnology company reported ($0.89) EPS for the quarter, topping the consensus estimate of ($1.02) by $0.13. Bellerophon Therapeutics has generated ($2.95) earnings per share over the last year. BLPH - Bellerophon Ther Com News - Barchart.com Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar. Benzinga Pro's Top 5 Stocks To Watch For Wed., Feb. 19 ...
Bellerophon Therapeutics (NASDAQ:BLPH) Earnings Information. Bellerophon Therapeutics last posted its quarterly earnings results on May 11th, 2020. The biotechnology company reported ($0.89) EPS for the quarter, topping the consensus estimate of ($1.02) by $0.13. Bellerophon Therapeutics has generated ($2.95) earnings per share over the last year.
Bellerophon Therapeutics, Inc. focuses on developing products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. BLPH Stock Quote of Bellerophon Ther Com Check out our BLPH stock analysis, current BLPH quote, charts, and historical prices for Bellerophon Ther Com stock Bellerophon Therapeutics (NYSE:BLPH) - Benzinga Feb 19, 2020 BLPH (Bellerophon Therapeutics) Stock Price and Chart ... BLPH: More Clinical Data Supports Utility of INOpulse, Near-Term Value-Inflection Opportunities Grow Zacks Small Cap Research Oct-23-19 12:30PM Bellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual
28 Aug 2018 Bellerophon Therapeutics, Inc. (BLPH) could be a stock to avoid from a technical perspective.
Zacks Investment Research Page 2 scr.zacks.com SNAPSHOT Bellerophon Therapeutics, Inc. (BLPH) is a clinical development-stage medical therapeutics company focused on the development and commercialization of a novel nitric oxide therapy which, if successfully fully developed and BLPH: More Clinical Data Supports Utility of INOpulse ... Oct 28, 2019 Zacks: Bellerophon Therapeutics Inc (NASDAQ:BLPH) Given ... Shares of Bellerophon Therapeutics Inc (NASDAQ:BLPH) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the three analysts that cover the stock, Zacks Investment Research reports. Three analysts have rated the stock with a strong buy recommendation. Brokerages have set a 1 year consensus price objective of $35.93 for the company […]
BLPH: Bellerophon Therapeutics Inc options chain stock quote. Get the latest options chain stock quote information from Zacks Investment Research.
Bellerophon Therapeutics, Inc. (BLPH) Latest Stock News ... Get the latest Bellerophon Therapeutics, Inc. (BLPH) stock news and headlines to help you in your trading and investing decisions. Analysts Recommended this Stock: Bellerophon Therapeutics ... Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) belonging to the Medical sector has declined -4.73% and closed its last trading session at $1.61. The company reported its EPS on 11/08/2016. Currently, the stock has a 1 Year Price Target of $5. The consensus recommendation, according to Zacks Investment research, is 1. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a
BBI Awaits Data In Q2, BLPH Breathes Easy, Big Day For BXRX Tomorrow Baudax Bio's stock soars on FDA approval of non-opioid pain drug after two Zacks: Brokerages Set $13.67 Target Price for Baudax Bio (NASDAQ:BXRX).
BLPH Stock Quote of Bellerophon Ther Com Check out our BLPH stock analysis, current BLPH quote, charts, and historical prices for Bellerophon Ther Com stock Bellerophon Therapeutics (NYSE:BLPH) - Benzinga Feb 19, 2020